D T O'Connor

发表

Molecular Cloning, Structure, and Expression of Dopamine‐β–Hydroxylase from Bovine Adrenal Medulla

D. O'Connor, D. Rozansky, R. J. Parmer, 1990, Journal of neurochemistry.

Cardiovascular haemodynamic response to repeated mental stress in normotensive subjects at genetic risk of hypertension: evidence of enhanced reactivity, blunted adaptation, and delayed recovery

D. O'Connor, R. Gevirtz, D T O'Connor, 2003, Journal of Human Hypertension.

Structure and function of the chromogranin A gene. Clues to evolution and tissue-specific expression.

D. O'Connor, D. Rozansky, H J Wu, 1991, The Journal of biological chemistry.

Desensitization of Catecholamine Release

S. Mahata, M. Mahata, R J Parmer, 1999, The Journal of Biological Chemistry.

Formation of the Catecholamine Release-inhibitory Peptide Catestatin from Chromogranin A

H Wu, R J Parmer, D T O'Connor, 2000, The Journal of Biological Chemistry.

Arterial compliance by cuff sphygmomanometer. Application to hypertension and early changes in subjects at genetic risk.

D. O'Connor, A. Demaria, T. Brinton, 1996, Hypertension.

Primary structure and function of the catecholamine release inhibitory peptide catestatin (chromogranin A(344-364)): identification of amino acid residues crucial for activity.

D T O'Connor, S K Mahata, M Mahata, 2000, Molecular endocrinology.

Catecholamine secretory vesicles. Augmented chromogranins and amines in secondary hypertension.

D. O'Connor, B. Kennedy, M. Ziegler, 1993, Hypertension.

Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist.

D. O'Connor, S. Yoo, H. Wu, 1997, The Journal of clinical investigation.